Structure adaptation in Omicron SARS-CoV-2/hACE2: Biophysical origins of evolutionary driving forces.


Journal

Biophysical journal
ISSN: 1542-0086
Titre abrégé: Biophys J
Pays: United States
ID NLM: 0370626

Informations de publication

Date de publication:
17 10 2023
Historique:
received: 14 12 2022
revised: 20 05 2023
accepted: 12 09 2023
pmc-release: 17 10 2024
medline: 23 10 2023
pubmed: 17 9 2023
entrez: 17 9 2023
Statut: ppublish

Résumé

Since its emergence, the COVID-19 threat has been sustained by a series of transmission waves initiated by new variants of the SARS-CoV-2 virus. Some of these arise with higher transmissivity and/or increased disease severity. Here, we use molecular dynamics simulations to examine the modulation of the fundamental interactions between the receptor binding domain (RBD) of the spike glycoprotein and the host cell receptor (human angiotensin-converting enzyme 2 [hACE2]) arising from Omicron variant mutations (BA.1 and BA.2) relative to the original wild-type strain. Our key findings are that glycans play a vital role at the RBD···hACE2 interface for the Omicrons, and the interplay between glycans and sequence mutations leads to enhanced binding. We find significant structural differences in the complexes, which overall bring the spike protein and its receptor into closer proximity. These are consistent with and attributed to the higher positive charge on the RBD conferred by BA.1 and BA.2 mutations relative to the wild-type. However, further differences between subvariants BA.1 and BA.2 (which have equivalent RBD charges) are also evident: mutations reduce interdomain interactions between the up chain and its clockwise neighbor chain in particular for the latter, resulting in enhanced flexibility for BA.2. Consequently, we see occurrence of additional close contacts in one replica of BA.2, which include binding to hACE2 by a second RBD in addition to the up chain. Although this motif is not seen in BA.1, we find that the Omicrons can directly/indirectly bind a down-RBD to hACE2 through glycans: the role of the glycan on N90 of hACE2 switches from inhibiting to facilitating the binding to Omicron spike protein via glycan-protein lateral interactions. These structural and electrostatic differences offer further insight into the mechanisms by which viral mutations modulate host cell binding and provide a biophysical basis for evolutionary driving forces.

Identifiants

pubmed: 37717145
pii: S0006-3495(23)00580-5
doi: 10.1016/j.bpj.2023.09.003
pmc: PMC10624932
pii:
doi:

Substances chimiques

Angiotensin-Converting Enzyme 2 EC 3.4.17.23
Spike Glycoprotein, Coronavirus 0
Polysaccharides 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4057-4067

Informations de copyright

Copyright © 2023 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Infect Drug Resist. 2021 Dec 01;14:5099-5105
pubmed: 34880635
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Sci Rep. 2022 May 20;12(1):8540
pubmed: 35595778
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
J Med Chem. 2022 Feb 24;65(4):2820-2826
pubmed: 33834772
Sci Rep. 2017 Jul 27;7(1):6713
pubmed: 28751750
Nature. 2022 Feb;602(7898):657-663
pubmed: 35016194
Cell. 2022 Aug 4;185(16):2952-2960.e10
pubmed: 35809570
FEBS Lett. 2021 May;595(10):1454-1461
pubmed: 33728680
Glycobiology. 2020 Dec 9;30(12):981-988
pubmed: 32363391
J Comput Chem. 2013 Sep 30;34(25):2135-45
pubmed: 23832629
Cell. 2019 Feb 21;176(5):1026-1039.e15
pubmed: 30712865
Sci Rep. 2020 Sep 14;10(1):14991
pubmed: 32929138
Cell Host Microbe. 2022 Aug 10;30(8):1093-1102.e3
pubmed: 35526534
Science. 2020 Sep 4;369(6508):1261-1265
pubmed: 32753553
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Biochim Biophys Acta Gen Subj. 2019 Oct;1863(10):1480-1497
pubmed: 31121217
J Phys Chem B. 2020 Aug 20;124(33):7128-7137
pubmed: 32559081
Phys Chem Chem Phys. 2022 Apr 13;24(15):8724-8737
pubmed: 35373810
J Chem Theory Comput. 2009 Aug 20;5(9):2353-2370
pubmed: 20161005
J Phys Chem Lett. 2020 Jun 18;11(12):4897-4900
pubmed: 32478523
Mol Biol Evol. 2021 Jun 25;38(7):2715-2731
pubmed: 33674876
J Phys Chem B. 2022 Apr 21;126(15):2812-2823
pubmed: 35403431
EMBO J. 2005 Apr 20;24(8):1634-43
pubmed: 15791205
J Chem Phys. 2020 Jul 28;153(4):044130
pubmed: 32752662
J Phys Chem Lett. 2022 May 5;13(17):3915-3921
pubmed: 35481766
Biochem Biophys Res Commun. 2022 Jan 29;590:34-41
pubmed: 34968782
Nature. 2020 May;581(7807):221-224
pubmed: 32225175
Proc Natl Acad Sci U S A. 2021 May 11;118(19):
pubmed: 33903171
Curr Opin Struct Biol. 2016 Oct;40:153-162
pubmed: 27792989
Elife. 2021 Aug 20;10:
pubmed: 34414884
Glycobiology. 2019 Apr 1;29(4):320-331
pubmed: 30689864
Biophys J. 2022 Jan 4;121(1):79-90
pubmed: 34883069
Nature. 2021 Aug;596(7871):276-280
pubmed: 34237773
Science. 2022 Mar 4;375(6584):1048-1053
pubmed: 35133176
Cell. 2022 Feb 3;185(3):457-466.e4
pubmed: 34995482
Glycobiology. 2021 May 3;31(4):410-424
pubmed: 33135055
Science. 2020 Jul 17;369(6501):330-333
pubmed: 32366695
ACS Cent Sci. 2020 Oct 28;6(10):1722-1734
pubmed: 33140034
J Am Chem Soc. 2021 Aug 4;143(30):11349-11360
pubmed: 34270232
Viruses. 2021 May 17;13(5):
pubmed: 34067878

Auteurs

Ya-Wen Hsiao (YW)

The Hartree Centre, STFC Daresbury Laboratory, Warrington, United Kingdom; Scientific Computing Department, STFC Daresbury Laboratory, Warrington, United Kingdom. Electronic address: ya-wen.hsiao@stfc.ac.uk.

David J Bray (DJ)

The Hartree Centre, STFC Daresbury Laboratory, Warrington, United Kingdom.

Tseden Taddese (T)

The Hartree Centre, STFC Daresbury Laboratory, Warrington, United Kingdom.

Guadalupe Jiménez-Serratos (G)

The Hartree Centre, STFC Daresbury Laboratory, Warrington, United Kingdom.

Jason Crain (J)

IBM Research Europe, Hartree Centre, Warrington, United Kingdom; Department of Biochemistry, University of Oxford, Oxford, United Kingdom. Electronic address: jason.crain@ibm.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH